Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ribavirin in the treatment of chronic hepatitis C.

Journal of gastroenterology and hepatology - 1 Jun 2008

Martin Paul, Jensen Donald M

Abstract excerpt

BACKGROUND AND AIM: Current practice guidelines recommend that individuals chronically infected with the hepatitis C virus (HCV) be treated with pegylated interferon plus ribavirin. Ribavirin, however, is associated with serious adverse events (AE), especially anemia. We review its mechanism of action, its importance in treating chronic hepatitis C (CHC) patients, the AE associated with its use, and techniques...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Administration Schedule
Share to Drug Therapy, Combination
Share to Evidence-Based Medicine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon-alpha

Share to Interferon alpha-2

Share to Polyethylene Glycols

Share to Practice Guidelines as Topic

Share to Ribavirin

Source

Identifiers

PMID: 18565019
DOI: 10.1111/j.1440-1746.2008.05398.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ribavirin in the treatment of chronic hepatitis C.PMID 18565019Read ↗

Ribavirin in the treatment of hepatitis C.Semantic proximity Read ↗

Pharmacogenetics of ribavirin-induced anemia in HCV patients.Semantic proximity Read ↗

Ribavirin revisited in the era of direct-acting antiviral therapy for hepatitis C virus infection.Semantic proximity Read ↗

Antiviral therapy in hepatitis C virus cirrhotic patients in compensated and decompensated condition.Semantic proximity Read ↗

Role of ribavirin in interferon-free therapy for the treatment of hepatitisC virus.Semantic proximity Read ↗

Ribavirin: current role in the optimal clinical management of chronic hepatitis C.Semantic proximity Read ↗

Ideal oral combinations to eradicate HCV: The role of ribavirin.Semantic proximity Read ↗

Safety aspects of protease inhibitors for chronic hepatitis C: adverse events and drug-to-drug interactions.Semantic proximity Read ↗

The cost of treating ribavirin-induced anemia in hepatitis C: the impact of using recombinant human erythropoietin.Semantic proximity Read ↗

Randomized study of peginterferon-alpha2a plus ribavirin vs peginterferon-alpha2b plus ribavirin in chronic hepatitis C.Semantic proximity Read ↗

Combination therapy with interferon-alpha and ribavirin for hepatitis C: practical treatment issues.Semantic proximity Read ↗

Peginterferon and ribavirin treatment for hepatitis C virus infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.